Due to insufficient retrieved dropout data (that is, data from participants who discontinued treatment but remained in the study), a control-based imputation approach using the placebo group was selected as a more conservative strategy
Specifically, in the group of patients prescribed semaglutide for weight loss, 6.7% developed NAION compared to just 0.8% of those on other treatments
Zepbound vs Mounjaro and Ozempic While Mounjaro and Ozempic are currently only approved by the FDA for treatment of Type 2 diabetes, it doesn't necessarily mean you won't be able to access these medications
J Neuroinflammation 1:22, PMID: 15527505 Moylan S, Maes M, Wray NR, Berk M (2013) The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications
The literature review has confirmed that both Semaglutide and Zepbound are well-suited to be used as weight reducing agents